Article Details

Click Therapeutics Announces FDA Marketing Authorization for CT-132, the First ... - BioSpace

Retrieved on: 2025-04-15 18:31:44

Tags for this article:

Click the tags to see associated articles and topics

Click Therapeutics Announces FDA Marketing Authorization for CT-132, the First ... - BioSpace. View article details on hiswai:

Excerpt

... digital therapeutic for the preventive treatment of episodic migraine in the United States. FDA marketing authorization for CT-132 is supported by ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo